These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6204636)

  • 1. Antibody combining sites can be mimicked synthetically. Surface-simulation synthesis of the phosphorylcholine-combining site of myeloma protein M-603.
    Kazim AL; Atassi MZ
    Biochem J; 1980 Jun; 187(3):661-6. PubMed ID: 6204636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A synthetic peptide corresponding to the phosphorylcholine (PC)-binding region of human C-reactive protein possesses the TEPC-15 myeloma PC-idiotype.
    Swanson SJ; Lin BF; Mullenix MC; Mortensen RF
    J Immunol; 1991 Mar; 146(5):1596-601. PubMed ID: 1704398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to phosphorylcholine. I. Characterization of the epitope-specific antibody.
    Kluskens L; Lee W; Köhler H
    Eur J Immunol; 1976 Jul; 5(7):489-96. PubMed ID: 61872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual binding specificities in MOPC 384 and 870 murine myeloma immunoglobulins.
    Bhattacharjee AK; Glaudemans CP
    J Immunol; 1978 Feb; 120(2):411-3. PubMed ID: 74386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific isolation and characterization of antibody directed to binding site antigenic determinants.
    Claflin JL; Davie JM
    J Immunol; 1975 Jan; 114(1 Pt 1):70-5. PubMed ID: 46246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of phosphorylcholine binding to antibodies using synthetic peptides.
    Lai EH; Kabat EA; Meienhofer J; Heimer EP; Olson AJ; Lerner R
    Nature; 1987 Jan 8-14; 325(7000):168-71. PubMed ID: 3808074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. kappa Chain variable region from M167, a phosphorylcholine binding myeloma protein.
    Rudikoff S; Potter M
    Biochemistry; 1978 Jul; 17(14):2703-7. PubMed ID: 99160
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological properties of myeloma proteins.
    Osterland CK; Espinoza LR
    Arch Intern Med; 1975 Jan; 135(1):32-6. PubMed ID: 46144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uniformity in the clonal repertoire for the immune response to phosphorylcholine in mice.
    Claflin JL
    Eur J Immunol; 1976 Oct; 6(10):669-74. PubMed ID: 65140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of heavy chain tyrosine 33 in the binding site of myeloma protein McPC 603 by paired label iodination.
    Grossberg AL; Roholt OA; Pressman D
    J Immunol; 1976 Jun; 116(6):1596-600. PubMed ID: 818315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific antigens inhibit plasmacytoma cells bearing phosphorylcholine-binding myeloma proteins.
    Kim BS; Rowley DA; Mallat L
    Cell Immunol; 1978 Dec; 41(2):286-93. PubMed ID: 83200
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-receptor antibody. I. Isolation and characterization of the immunoglobulin receptor for phosphorylcholine.
    Strayer DS; Vitetta ES; Köhler H
    J Immunol; 1975 Feb; 114(2 pt 2):722-7. PubMed ID: 46887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can an antibody-combining site be mimicked synthetically? The possible surface simulation synthesis of two antibody-combining sites complementary to two antigenic sites of lysozyme.
    Atassi MZ; Zablocki W
    J Biol Chem; 1977 Dec; 252(24):8784-7. PubMed ID: 925023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic memory to phosphorylcholine. II. PC-KLH induces two antibody populations that dominate different isotypes.
    Chang SP; Brown M; Rittenberg MB
    J Immunol; 1982 Feb; 128(2):702-6. PubMed ID: 7054294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-binding myeloma proteins of mice.
    Potter M
    Adv Immunol; 1977; 25():141-211. PubMed ID: 76433
    [No Abstract]   [Full Text] [Related]  

  • 16. Affinity labeling and topology of the antibody combining site.
    Givol D
    Essays Biochem; 1974; 10():73-103. PubMed ID: 4140089
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the secondary structures and binding sites of C-reactive protein and the phosphorylcholine-binding murine myeloma proteins.
    Young NM; Williams RE
    J Immunol; 1978 Nov; 121(5):1893-8. PubMed ID: 30801
    [No Abstract]   [Full Text] [Related]  

  • 18. Attempts to locate residues in complementarity-determining regions of antibody combining sites that make contact with antigen.
    Kabat EA; Wu TT; Bilofsky H
    Proc Natl Acad Sci U S A; 1976 Feb; 73(2):617-9. PubMed ID: 1061162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to synthetic antibody-combining sites. Antibodies against a surface-simulation peptide with antibody-combining activity toward lysozyme antigenic site 3 react with lysozyme antibodies.
    Atassi MZ; Sakata S
    Biochim Biophys Acta; 1980 Aug; 624(2):573-8. PubMed ID: 6158339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precise determination of protein antigenic structures has unravelled the molecular immune recognition of proteins and provided a prototype for synthetic mimicking of other protein binding sites.
    Atassi MZ
    Mol Cell Biochem; 1980 Aug; 32(1):21-43. PubMed ID: 6160381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.